Andratschke M - Search Results

1

Biodistribution of 131I-labeled anti-CK8 monoclonal antibody in HNSCC in xenotransplanted SCID mice.

Andratschke M, Luebbers CW, Johannson V, Schmitt B, Mack B, Zeidler R, Lang S, Wollenberg B, Gildehaus FJ. Andratschke M, et al. Anticancer Res. 2011 Oct;31(10):3315-21. Anticancer Res. 2011. PMID: 21965741

2

Soluble CD44v6 is not a sensitive tumor marker in patients with head and neck squamous cell cancer.

Andratschke M, Chaubal S, Pauli C, Mack B, Hagedorn H, Wollenberg B. Andratschke M, et al. Anticancer Res. 2005 Jul-Aug;25(4):2821-6. Anticancer Res. 2005. PMID: 16080532 Free article.

3

Limited suitability of EpCAM for molecular staging of tumor borders in head and neck cancer.

Andratschke M, Hagedorn H, Luebbers CW, Schmitt B, Lang S, Zeidler R, Wollenberg B. Andratschke M, et al. Anticancer Res. 2006 Jan-Feb;26(1A):153-8. Anticancer Res. 2006. PMID: 16475692 Free article.

4

Biodistribution and radioimmunotherapy of SCCHN in xenotransplantated SCID mice with a 131I-labelled anti-EpCAM monoclonal antibody.

Andratschke M, Gildehaus FJ, Johannson V, Schmitt B, Mack B, Reisbach G, Lang S, Lindhofer H, Zeidler R, Wollenberg B, Luebbers CW. Andratschke M, et al. Anticancer Res. 2007 Jan-Feb;27(1A):431-6. Anticancer Res. 2007. PMID: 17352264 Free article.

5

Allogenic antibody-mediated identification of head and neck cancer antigens.

Rauch J, Ahlemann M, Schaffrik M, Mack B, Ertongur S, Andratschke M, Zeidler R, Lang S, Gires O. Rauch J, et al. Among authors: andratschke m. Biochem Biophys Res Commun. 2004 Oct 8;323(1):156-62. doi: 10.1016/j.bbrc.2004.08.071. Biochem Biophys Res Commun. 2004. PMID: 15351715

6

Generation of an autologous cell system for immunotherapy of squamous cell carcinoma of the head and neck.

Mayer A, Andratschke M, Pauli C, Graefe H, Kristina K, Wollenberg B. Mayer A, et al. Among authors: andratschke m. Anticancer Res. 2005 Nov-Dec;25(6B):4075-80. Anticancer Res. 2005. PMID: 16309201 Free article.

7

Prednisolone reduces TNF-alpha release by PBMCs activated with a trifunctional bispecific antibody but not their anti-tumor activity.

Walz A, Andratschke M, Wollenberg B, Lindhofer H, Zeidler R. Walz A, et al. Among authors: andratschke m. Anticancer Res. 2005 Nov-Dec;25(6B):4239-43. Anticancer Res. 2005. PMID: 16309222 Free article.

8

Immune restoration in head and neck cancer patients after in vivo COX-2 inhibition.

Lang S, Tiwari S, Andratschke M, Loehr I, Lauffer L, Bergmann C, Mack B, Lebeau A, Moosmann A, Whiteside TL, Zeidler R. Lang S, et al. Among authors: andratschke m. Cancer Immunol Immunother. 2007 Oct;56(10):1645-52. doi: 10.1007/s00262-007-0312-5. Epub 2007 Mar 27. Cancer Immunol Immunother. 2007. PMID: 17387473 Free PMC article.

9

The significance of Tenascin-C serum level as tumor marker in squamous cell carcinoma of the head and neck.

Pauli C, Stieber P, Schmitt UM, Andratschke M, Hoffmann K, Wollenberg B. Pauli C, et al. Among authors: andratschke m. Anticancer Res. 2002 Sep-Oct;22(5):3093-7. Anticancer Res. 2002. PMID: 12530049

10

MHC-class I antigen expression on micrometastases in bone marrow of patients with head and neck squamous cell cancer.

Andratschke M, Pauli C, Stein M, Chaubal S, Wollenberg B. Andratschke M, et al. Anticancer Res. 2003 Mar-Apr;23(2B):1467-71. Anticancer Res. 2003. PMID: 12820411

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

37 results

Search Page